These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19440855)

  • 61. Comparison of three mathematical models for predicting the risk of additional axillary nodal metastases after positive sentinel lymph node biopsy in early breast cancer.
    Moghaddam Y; Falzon M; Fulford L; Williams NR; Keshtgar MR
    Br J Surg; 2010 Nov; 97(11):1646-52. PubMed ID: 20641049
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Predicting the likelihood of nonsentinel lymph node metastases in triple negative breast cancer patients with a positive sentinel lymph node: Turkish Federation of Breast Disease Associations protocol MF09-01.
    Ozbas S; Ozmen V; Igci A; Muslumanoglu M; Ozcinar B; Balkan M; Aydogan F; Canda T; Harmancioglu O; Aksaz E; Gulluoglu BM; Kayahan M; Ozaslan C; Canturk NZ; Mersin H; Utkan Z; Kocak S; Ulufi N; Polat AK; Andacoglu O; Soran A
    Clin Breast Cancer; 2012 Feb; 12(1):63-7. PubMed ID: 22130034
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Value of Memorial Sloan-Kettering Cancer Center nomogram in clinical decision making for sentinel lymph node-positive breast cancer.
    van den Hoven I; Kuijt GP; Voogd AC; van Beek MW; Roumen RM
    Br J Surg; 2010 Nov; 97(11):1653-8. PubMed ID: 20641050
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Application of a predictive model of axillary lymph node status in patients with sentinel node metastasis from breast cancer. A retrospective cohort study.
    Vieni S; Graceffa G; La Mendola R; Latteri S; Cordova A; Latteri MA; Cipolla C
    Int J Surg; 2016 Nov; 35():58-63. PubMed ID: 27633450
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Applicability of two different validated models to predict axillary non-sentinel lymph node status by sentinel node biopsy in a single Italian center.
    Bertozzi S; Londero AP; Giacomuzzi F; Angione V; Carbone A; Petri R; Bernardi S
    Breast Cancer; 2015 Jul; 22(4):350-5. PubMed ID: 23832256
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Low performance of the MSKCC nomogram in preoperatively ultrasonically negative axillary lymph node in breast cancer patients.
    Zgajnar J; Perhavec A; Hocevar M; Podkrajsek M; Hertl K; Frkovic-Grazio S; Pohar M; Besic N
    J Surg Oncol; 2007 Dec; 96(7):547-53. PubMed ID: 17708546
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram.
    Specht MC; Kattan MW; Gonen M; Fey J; Van Zee KJ
    Ann Surg Oncol; 2005 Aug; 12(8):654-9. PubMed ID: 16021535
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Models to predict non sentinel lymph node status in breast cancer patients with metastatic sentinel lymph node].
    Coutant C; Rouzier R; Olivier C; Bezu C; Marpeau O; Delpech Y; Uzan S; Daraï E
    Gynecol Obstet Fertil; 2009 Feb; 37(2):160-6. PubMed ID: 19119050
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers.
    Bonsang-Kitzis H; Mouttet-Boizat D; Guillot E; Feron JG; Fourchotte V; Alran S; Pierga JY; Cottu P; Lerebours F; Stevens D; Vincent-Salomon A; Sigal-Zafrani B; Campana F; Rouzier R; Reyal F
    PLoS One; 2017; 12(2):e0169962. PubMed ID: 28241044
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Validation of a nomogram predicting sentinel lymph node status in melanoma in an Irish population.
    Woods JF; De Marchi JA; Lowery AJ; Hill AD
    Ir J Med Sci; 2015 Dec; 184(4):769-73. PubMed ID: 24997756
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Validating the MSKCC nomogram and a clinical decision rule in the prediction of non-sentinel node metastases in a Portuguese population of breast cancer patients.
    Fougo JL; Senra FS; Araújo C; Dias T; Afonso M; Leal C; Dinis-Ribeiro M
    Breast; 2011 Apr; 20(2):134-40. PubMed ID: 21109437
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A simple nomogram to evaluate the risk of nonsentinel node metastases in breast cancer patients with minimal sentinel node involvement.
    Meretoja TJ; Strien L; Heikkilä PS; Leidenius MH
    Ann Surg Oncol; 2012 Feb; 19(2):567-76. PubMed ID: 21792511
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Validation of nomograms to predict the risk of non-sentinels lymph node metastases in North African Tunisian breast cancer patients with sentinel node involvement.
    Hidar S; Harrabi I; Benregaya L; Fatnassi R; Khelifi A; Benabdelkader A; Trabelsi A; Bouaouina N; Ben Ahmed S; Bibi M; Khaïri H
    Breast; 2011 Feb; 20(1):26-30. PubMed ID: 20729084
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Validation and comparison of models to predict non-sentinel lymph node metastasis in breast cancer patients.
    Chen K; Zhu L; Jia W; Rao N; Fan M; Huang H; Shan Q; Han J; Song E; Zeng Y; Su F
    Cancer Sci; 2012 Feb; 103(2):274-81. PubMed ID: 22054165
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Use of Memorial Sloan Kettering Cancer Center nomogram to guide intraoperative sentinel lymph node frozen sections in patients with early breast cancer.
    Houpu Y; Fei X; Yang Y; Fuzhong T; Peng L; Bo Z; Lin C; Yingming C; Miao L; Hongjun L; Siyuan W; Yuan P; Danhua S; Shu W
    J Surg Oncol; 2019 Sep; 120(4):587-592. PubMed ID: 31309573
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Elaboration of a nomogram to predict non sentinel node status in breast cancer patients with positive sentinel node, intra-operatively assessed with one step nucleic acid amplification method.
    Di Filippo F; Giannarelli D; Bouteille C; Bernet L; Cano R; Cunnick G; Sapino A
    J Exp Clin Cancer Res; 2015 Nov; 34():136. PubMed ID: 26538019
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A new and simple predictive formula for non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph nodes, and validation of 3 different nomograms in Turkish breast cancer patients.
    Yeniay L; Carti E; Karaca C; Zekioglu O; Yararbas U; Yilmaz R; Kapkac M
    Breast Care (Basel); 2012 Oct; 7(5):397-402. PubMed ID: 24647780
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Analysis of clinical applicability of the breast cancer nomogram for positive sentinel lymph node: the canadian experience.
    Poirier E; Sideris L; Dubé P; Drolet P; Meterissian SH
    Ann Surg Oncol; 2008 Sep; 15(9):2562-7. PubMed ID: 18618183
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A mathematical prediction model incorporating molecular subtype for risk of non-sentinel lymph node metastasis in sentinel lymph node-positive breast cancer patients: a retrospective analysis and nomogram development.
    Wang NN; Yang ZJ; Wang X; Chen LX; Zhao HM; Cao WF; Zhang B
    Breast Cancer; 2018 Nov; 25(6):629-638. PubMed ID: 29696563
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram.
    Cripe MH; Beran LC; Liang WC; Sickle-Santanello BJ
    Am J Surg; 2006 Oct; 192(4):484-7. PubMed ID: 16978955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.